Company Overview - Masimo Corporation, based in Irvine, CA, develops, manufactures, and markets non-invasive monitoring systems [11] - The company operates in two segments: Healthcare revenues account for 62.3% of FY23 revenues, which is a decrease of 4.8% from FY22, while Non-healthcare revenues make up 37.7%, showing an increase of 11.1% [11] Investment Ratings - Masimo is rated as a 1 (Strong Buy) on the Zacks Rank, indicating strong investment potential [11] - The company has a VGM Score of B, which combines value, growth, and momentum indicators [11][12] Momentum and Earnings Estimates - The Momentum Style Score for Masimo is A, with shares having increased by 8.4% over the past four weeks [12] - In the last 60 days, five analysts have revised their earnings estimates upwards for fiscal 2025, with the Zacks Consensus Estimate rising by $0.50 to $5.07 per share [12] - Masimo has an average earnings surprise of 14.4%, indicating strong performance relative to expectations [12]
Here's Why Masimo (MASI) is a Strong Momentum Stock